These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10217061

  • 21. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK.
    Brain Res; 1983 Dec 19; 289(1-2):375-9. PubMed ID: 6362777
    [Abstract] [Full Text] [Related]

  • 22. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH.
    Fed Proc; 1986 Dec 19; 45(13):2982-8. PubMed ID: 2430839
    [Abstract] [Full Text] [Related]

  • 23. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Davies P.
    Brain Res; 1979 Aug 03; 171(2):319-27. PubMed ID: 37989
    [Abstract] [Full Text] [Related]

  • 24. Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications.
    Mesulam MM, Volicer L, Marquis JK, Mufson EJ, Green RC.
    Ann Neurol; 1986 Feb 03; 19(2):144-51. PubMed ID: 3963756
    [Abstract] [Full Text] [Related]

  • 25. gamma-Glutamyltransferase: normal cortical levels in Alzheimer disease.
    McGeer EG, Singh EA, McGeer PL.
    Alzheimer Dis Assoc Disord; 1987 Feb 03; 1(1):38-42. PubMed ID: 2899437
    [Abstract] [Full Text] [Related]

  • 26. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
    DeKosky ST, Scheff SW, Markesbery WR.
    Neurology; 1985 Oct 03; 35(10):1425-31. PubMed ID: 4033925
    [Abstract] [Full Text] [Related]

  • 27. Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.
    Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TT.
    Lancet; 1981 Jul 18; 2(8238):149. PubMed ID: 6113507
    [No Abstract] [Full Text] [Related]

  • 28. Overview of morphological changes in Parkinson's disease.
    Jellinger K.
    Adv Neurol; 1987 Jul 18; 45():1-18. PubMed ID: 3825687
    [No Abstract] [Full Text] [Related]

  • 29. Selective loss of central cholinergic neurons in Alzheimer's disease.
    Davies P, Maloney AJ.
    Lancet; 1976 Dec 25; 2(8000):1403. PubMed ID: 63862
    [No Abstract] [Full Text] [Related]

  • 30. [A biochemical study of cholinergic neurons of the post-mortem brains from the patients with Alzheimer-type dementia].
    Arai H, Kosaka K, Muramoto O, Iizuka R.
    Rinsho Shinkeigaku; 1984 Nov 25; 24(11):1128-35. PubMed ID: 6518703
    [No Abstract] [Full Text] [Related]

  • 31. Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.
    Lehéricy S, Hirsch EC, Cervera P, Hersh LB, Hauw JJ, Ruberg M, Agid Y.
    Proc Natl Acad Sci U S A; 1989 Nov 25; 86(21):8580-4. PubMed ID: 2682652
    [Abstract] [Full Text] [Related]

  • 32. Acetylcholinesterase fibers and the development of senile plaques.
    Tago H, McGeer PL, McGeer EG.
    Brain Res; 1987 Mar 17; 406(1-2):363-9. PubMed ID: 3567634
    [Abstract] [Full Text] [Related]

  • 33. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.
    Mann DM, Yates PO.
    J Neurol Neurosurg Psychiatry; 1982 Oct 17; 45(10):936. PubMed ID: 7143014
    [No Abstract] [Full Text] [Related]

  • 34. [Experimental pharmacology of Alzheimer's disease].
    Miyoshi K, Ueki A.
    Nihon Rinsho; 1985 Jul 17; 43(7):1423-7. PubMed ID: 3903265
    [No Abstract] [Full Text] [Related]

  • 35. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM, Bruce G, Hersh LB, Terry RD.
    Neurosci Lett; 1986 Nov 11; 71(2):229-34. PubMed ID: 2431362
    [Abstract] [Full Text] [Related]

  • 36. Laminar distributions of choline acetyltransferase and acetylcholinesterase activities in the inner plexiform layer of rat retina.
    Ross CD, Dunning DD, Juengel LI, Godfrey DA.
    J Neurochem; 1985 Apr 11; 44(4):1091-9. PubMed ID: 3973606
    [Abstract] [Full Text] [Related]

  • 37. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P.
    Res Publ Assoc Res Nerv Ment Dis; 1979 Apr 11; 57():153-66. PubMed ID: 33427
    [No Abstract] [Full Text] [Related]

  • 38. Biological markers and the cholinergic hypothesis in Alzheimer's disease.
    Nordberg A.
    Acta Neurol Scand Suppl; 1992 Apr 11; 139():54-8. PubMed ID: 1414270
    [No Abstract] [Full Text] [Related]

  • 39. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
    Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.
    Neurologia; 2014 Oct 11; 29(8):497-503. PubMed ID: 23433740
    [Abstract] [Full Text] [Related]

  • 40. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ.
    Brain Res; 1986 Apr 16; 371(1):146-51. PubMed ID: 3708340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.